Literature DB >> 10821852

SOCS-3 is an insulin-induced negative regulator of insulin signaling.

B Emanuelli1, P Peraldi, C Filloux, D Sawka-Verhelle, D Hilton, E Van Obberghen.   

Abstract

The SOCS proteins are induced by several cytokines and are involved in negative feedback loops. Here we demonstrate that in 3T3-L1 adipocytes, insulin, a hormone whose receptor does not belong to the cytokine receptor family, induces SOCS-3 expression but not CIS or SOCS-2. Using transfection of COS-7 cells, we show that insulin induction of SOCS-3 is enhanced upon Stat5B expression. Moreover, Stat5B from insulin-stimulated cells binds directly to a Stat element present in the SOCS-3 promoter. Once induced, SOCS-3 inhibits insulin activation of Stat5B without modifying the insulin receptor tyrosine kinase activity. Two pieces of evidence suggest that this negative regulation likely results from competition between SOCS-3 and Stat5B binding to the same insulin receptor motif. First, using a yeast two-hybrid system, we show that SOCS-3 binds to the insulin receptor at phosphotyrosine 960, which is precisely where Stat5B binds. Second, using confocal microscopy, we show that insulin induces translocation of SOCS-3 from an intracellular compartment to the cell membrane, leading to colocalization of SOCS-3 with the insulin receptor. This colocalization is dependent upon phosphorylation of insulin receptor tyrosine 960. Indeed, in cells expressing an insulin receptor mutant in which tyrosine 960 has been mutated to phenylalanine, insulin does not modify the cellular localization of SOCS-3. We have thus revealed an insulin target gene of which the expression is potentiated upon Stat5B activation. By inhibiting insulin-stimulated Stat5B, SOCS-3 appears to function as a negative regulator of insulin signaling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821852     DOI: 10.1074/jbc.275.21.15985

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  128 in total

1.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Trends Biochem Sci       Date:  2010-05-07       Impact factor: 13.807

Review 3.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 4.  [Intensive insulin therapy in sepsis. Improvement of survival chances?].

Authors:  M G Jeschke
Journal:  Anaesthesist       Date:  2003-12       Impact factor: 1.041

5.  Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes.

Authors:  Allison M Gaudy; Alicia H Clementi; Jean S Campbell; Alan V Smrcka; Robert A Mooney
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

6.  Signaling by retinol and its serum binding protein.

Authors:  Noa Noy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-10-29       Impact factor: 4.006

Review 7.  Impaired cardiac function in leptin-deficient mice.

Authors:  Jun Ren; Heng Ma
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 8.  Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity.

Authors:  Christopher D Morrison; Peter Huypens; Laura K Stewart; Thomas W Gettys
Journal:  Biochim Biophys Acta       Date:  2008-09-25

9.  Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.

Authors:  Ke-Xin Gan; Chao Wang; Jin-Hu Chen; Chun-Jing Zhu; Guang-Yao Song
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

10.  Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse.

Authors:  Kohjiro Ueki; Tatsuya Kondo; Yu-Hua Tseng; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.